NASDAQ:BSGM BioSig Technologies (BSGM) Stock Price, News & Analysis $5.85 -0.56 (-8.74%) Closing price 04:00 PM EasternExtended Trading$6.02 +0.17 (+2.91%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About BioSig Technologies Stock (NASDAQ:BSGM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioSig Technologies alerts:Sign Up Key Stats Today's Range$5.17▼$6.5050-Day Range$0.48▼$6.4152-Week Range$0.20▼$6.84Volume1.13 million shsAverage Volume289,250 shsMarket Capitalization$159.68 millionP/E RatioN/ADividend YieldN/APrice Target$2.50Consensus RatingBuy Company OverviewBioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More… BioSig Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreBSGM MarketRank™: BioSig Technologies scored higher than 17% of companies evaluated by MarketBeat, and ranked 877th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageBioSig Technologies has only been the subject of 1 research reports in the past 90 days.Read more about BioSig Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BioSig Technologies are expected to grow in the coming year, from ($0.88) to ($0.73) per share.Read more about BioSig Technologies' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BSGM. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for BSGM. News and Social Media3.9 / 5News Sentiment1.09 News SentimentBioSig Technologies has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for BioSig Technologies this week, compared to 0 articles on an average week.Search Interest64 people have searched for BSGM on MarketBeat in the last 30 days. This is an increase of 3,100% compared to the previous 30 days.MarketBeat Follows2 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders17.03% of the stock of BioSig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.16% of the stock of BioSig Technologies is held by institutions.Read more about BioSig Technologies' insider trading history. Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address BSGM Stock News HeadlinesCORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)May 28 at 6:45 PM | globenewswire.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of BioSig Technologies, Inc. (NASDAQ: BSGM)May 28 at 5:29 PM | financialpost.com“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.May 28, 2025 | Brownstone Research (Ad)$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of BioSig Technologies, Inc. (NASDAQ: BSGM)May 28 at 4:59 PM | globenewswire.comBioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment OfficerMay 28 at 1:46 PM | globenewswire.comBioSig Technologies signs definitive share exchange agreement with StreamexMay 28 at 12:35 AM | finance.yahoo.comBSGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of BioSig Technologies, Inc. Is Fair to ShareholdersMay 26 at 10:03 AM | businesswire.comBioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex AcquisitionMay 25 at 7:36 PM | insidermonkey.comSee More Headlines BSGM Stock Analysis - Frequently Asked Questions How have BSGM shares performed this year? BioSig Technologies' stock was trading at $1.49 at the start of the year. Since then, BSGM stock has increased by 292.6% and is now trading at $5.85. View the best growth stocks for 2025 here. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) announced its earnings results on Monday, May, 19th. The company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.09. When did BioSig Technologies' stock split? Shares of BioSig Technologies reverse split on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are BioSig Technologies' major shareholders? BioSig Technologies' top institutional shareholders include Legacy Wealth Managment LLC ID (25.63%), Cambridge Investment Research Advisors Inc. (1.55%) and PFG Investments LLC (0.92%). Insiders that own company stock include Kenneth L Londoner, Steve Chaussy, Patrick Joseph Gallagher, John Sieckhaus and Gray Fleming. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioSig Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Roku (ROKU) and Ford Motor (F). Company Calendar Last Earnings5/19/2025Today5/28/2025Next Earnings (Estimated)8/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:BSGM CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$2.50 Low Stock Price Target$2.50 Potential Upside/Downside-53.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.04 million Net Margins-44,832.50% Pretax Margin-39,405.12% Return on EquityN/A Return on Assets-776.49% Debt Debt-to-Equity RatioN/A Current Ratio0.50 Quick Ratio0.50 Sales & Book Value Annual Sales$26,000.00 Price / Sales5,584.98 Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-16.12Miscellaneous Outstanding Shares27,295,000Free Float14,300,000Market Cap$145.21 million OptionableNo Data Beta0.02 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:BSGM) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.